Skip to main content
$16.24 -$0.18 (-1.1%)

04:00 PM EDT on 10/22/21

Innoviva Inc. (NASDAQ:INVA)

CAPS Rating: 5 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Current Price $16.24 Mkt Cap $1.1B
Open $16.38 P/E Ratio 6.01
Prev. Close $16.24 Div. (Yield) $0.00 (0.0%)
Daily Range $16.19 - $16.41 Volume 252,475
52-Wk Range $9.21 - $17.45 Avg. Daily Vol. 863,530

Caps

How do you think NASDAQ:INVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

101 Outperform
29 Underperform
 

All-Star Players

20 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:INVA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

gklein711 (38.37)
Submitted January 08, 2008

Therevance appears to be a good company, but hit a rough spot. Should rebound from here.

zzlangerhans (99.01)
Submitted September 25, 2010

The recent bull charge has carried several baby biotechs and small pharmas out of their trading range without positive catalysts, which primes them for disproportionate drops as soon as the momentum inevitably shifts. Theravance has been bouncing… More

NASDAQ:INVA VS S&P 500 (SPY)

Fools bullish on NASDAQ:INVA are also bullish on:

Fools bearish on NASDAQ:INVA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about INVA.

Recs

0
Member Avatar mullerman58 (< 20) Submitted: 10/10/2021 4:33:29 PM : Outperform Start Price: $16.72 NASDAQ:INVA Score: -6.65

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma.

Recs

0
Member Avatar BernieRosa (62.52) Submitted: 1/8/2019 7:23:36 PM : Outperform Start Price: $19.00 NASDAQ:INVA Score: -90.15

Grow and more Grow!

Recs

0
Member Avatar LovinMe (23.81) Submitted: 11/30/2014 7:42:02 PM : Outperform Start Price: $14.48 NASDAQ:INVA Score: -106.99

Pharma isn't my favorite but I do like the valuation and dividend on this. Not without it's risks.

Leaderboard

Find the members with the highest scoring picks in INVA.

Score Leader

Evad005

Evad005 (< 20) Score: +430.56

The Score Leader is the player with the highest score across all their picks in INVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Evad005 < 20 3/25/2009 Underperform 3M $12.24 +33.12% +463.68% +430.56 0 Comment
jmacn22 26.68 2/5/2009 Underperform 3Y $11.97 +36.23% +443.96% +407.73 1 Comment
anticitradeshort 27.71 4/20/2009 Underperform NS $10.36 +57.32% +435.28% +377.95 0 Comment
qubit15 21.59 1/21/2009 Underperform NS $8.07 +102.11% +466.19% +364.09 0 Comment
schwah4 26.52 12/29/2008 Underperform NS $8.23 +98.13% +438.06% +339.93 0 Comment
haimp 26.64 10/7/2010 Underperform 5Y $15.87 +2.74% +291.16% +288.42 0 Comment
withoutlimits 85.98 10/1/2010 Underperform 5Y $14.84 +9.82% +294.08% +284.26 1 Comment
alexdowns77 89.70 10/1/2010 Underperform 5Y $14.54 +12.10% +296.32% +284.22 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $10.31 +58.11% +335.18% +277.07 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $10.31 +58.11% +335.18% +277.07 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INVA.